Celltrion (XKRX:068270) Additional Paid-In Capital : ₩14,790,160 Mil(As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Celltrion Additional Paid-In Capital?

Celltrion's quarterly additional paid-in capital declined from Jun. 2023 (₩879,643 Mil) to Sep. 2023 (₩872,543 Mil) but then increased from Sep. 2023 (₩872,543 Mil) to Dec. 2023 (₩14,790,160 Mil).

Celltrion's annual additional paid-in capital increased from Dec. 2021 (₩856,307 Mil) to Dec. 2022 (₩871,103 Mil) and increased from Dec. 2022 (₩871,103 Mil) to Dec. 2023 (₩14,790,160 Mil).

Celltrion Additional Paid-In Capital Historical Data

The historical data trend for Celltrion's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Additional Paid-In Capital Chart

Celltrion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

801,316.68

827,721.09

856,306.66

871,102.81

14,790,160.45

Celltrion Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															871,102.81	872,638.82	879,643.11	872,543.04	14,790,160.45

Celltrion Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Celltrion Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Celltrion's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Celltrion (XKRX:068270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840

Website

http://www.celltrion.com

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines